Gene therapy for cerebral vascular disease: update 2003

Area of Science:

• Cerebrovascular diseases
• Gene therapy
• Neuroprotection

Background:

• Gene therapy is a promising approach for cerebrovascular diseases.
• Current strategies involve gene transfer for vasospasm prevention and neuroprotection in ischemic stroke.
• Applications for coronary and limb arteries exist, but carotid and intracranial arteries are less explored.

Purpose of the Study:

• To review the current state and future potential of gene therapy for cerebrovascular diseases.
• To highlight objectives such as stimulating collateral vessel growth and plaque stabilization.
• To identify areas needing advancement for clinical application.

Main Methods:

• Review of existing literature on gene therapy for cerebrovascular conditions.
• Analysis of gene transfer strategies for specific cerebrovascular diseases (e.g., subarachnoid hemorrhage, ischemic stroke).
• Discussion of therapeutic goals and challenges in applying gene therapy to different arterial systems.

Main Results:

• Gene transfer via cerebrospinal fluid is used for vasospasm prevention post-subarachnoid hemorrhage.
• Neuroprotective gene transfer targeting inflammatory mediators is a strategy for ischemic stroke.
• Gene therapy objectives for peripheral arteries (collateral growth, plaque stabilization, thrombosis inhibition, restenosis prevention) have limited application in carotid and intracranial arteries.

Conclusions:

• Gene therapy holds promise for cerebrovascular diseases, with established methods for some conditions.
• Significant advances, particularly in developing safer vectors, are required.
• Further research is needed to translate gene therapy effectively to carotid and intracranial arteries for stroke treatment.